Rolling into #SXSW Interactive—most interested in where #health & #medtech collide with hype, hope & the occasional overuse of ‘disrupt.’ Expecting exciting ideas, real challenges & maybe a few surprises.

Life sciences innovation isn’t just about breakthroughs—it’s about funding, deal structure, IP & regulatory risks. Too many early-stage companies focus on science & overlook the business side. Our #SXSW Transactions Series breaks down what drives success: healthcarelawinsights.com/2025/03/naviga…

#TeamHB & Austin MedTech Connect tag teamed to host a breakfast session with USPTO Southwest Regional Director Hope Shimabuku—diving into key USPTO updates + top IP strategies for #medtech companies. Great insights shared! #sxsw

San Antonio ➝ Nashville ➝ Denver. Joined #healthcare client leadership teams this week to rethink strategy—growth, AI, regulation & defining success over the next 5 years. The best part of my job is being part of these conversations when the stakes are real. #healthlaw #TeamHB

The best part of receiving this recognition again is knowing it reflects the work we do alongside our clients—helping them grow, adapt & lead in a fast-changing industry. Congrats to my Husch Blackwell colleagues on AHLA’s top national ranking!

Most people were still negotiating with their snooze button. Our summer associates and HB colleagues were already clipped in—sweating it out in an early morning spin class. Practicing law takes focus and discipline. This crew shows up—with intention. #lawyerwellbeing #TeamHB

Big shift ahead for TX #healthcare non-competes. Starting Sept 1, SB 1318 adds new rules for physicians, nurses, PAs & dentists—capped buyouts, tighter limits & clearer terms. Whether you hire or practice, it’s time to plan. Details: huschblackwell.com/newsandinsight… #healthcare #TeamHB

Healthcare M&A hasn’t stopped, it’s just shifted. At ACG Austin/San Antonio Mid-Year Update, Chin Yu framed the story well: lower/mid-market deals are steady, especially in BH, RCM & infusion. Prep & alignment matter more than ever. #healthcare #privateequity #HalTheLawyer

There are a lot of great lawyers in Austin, so it means a lot to be included on this list. Thanks to austin_monthly & the peers who recognized those of us at Husch Blackwell who made the cut! #TeamHB huschblackwell.com/inthenews/eigh…

Themes shaping the 2025 AHA Summit: rethinking care delivery, improving the consumer experience, tackling workforce challenges, and building smarter partnerships. A lot to learn from hospitals innovating in real time across the country. #AHASummit

Physicians are behind much of today’s health innovation. At HLTH, we’ll keep it practical: protect what you build, set fair founder/advisor equity, and get deal-ready, without tripping tech-transfer, CPOM, or cap-table mishaps. #HLTH2025 tinyurl.com/47zyjzka

#HLTH2025 set the bar high yesterday: bold ideas and real substance. We build on that today. #TeamHB takes the stage tomorrow. ✨ #healthinnovation

AI feels everywhere. At #BHT2025 almost everyone had an AI story: navigation, docs, crisis prediction, self-guided + value-based care. Upside is real, but who pulls ahead, does access expand, and will payors ever reimburse? #healthtech #behavioralhealth

Kicking off the ABA Health Law Section Washington Health Law Summit. Big conversations ahead on where federal policy is heading and what it means for all of us. You’re missing out if you aren’t here. #healthlaw #healthpolicy #WHS2025

Proud moment at the ABA Health Law Section Washington Health Law Summit seeing Husch Blackwell ranked #1 in the 2025 Health Law Firm Recognition. Grateful to work alongside such an exceptional team. #WHS2025

Day one of ABA Health Law’s Washington Health Law Summit is done. CMMI as policy lab, value after 20 years, enforcement, cyber, AI, FTC on roll-ups. Honest conversations about hard problems. Now, onto day two. #WHS2025 #healthlaw #healthpolicy

Ahead of JPM Healthcare Week, the talk in provider services + health tech feels consistent: selectivity, structured deals (minority/earn-ins), more strategic JVs & more focus on fundamentals + adoption than narrative. #JPM2026 #TeamHB

Husch Blackwell partners Nick Healey and Tom O'Day continue their discussion of the fair hearings and larger peer review process and strategies to navigate it more effectively. Listen to the episode for actionable insights to help improve your practices. 🎧ow.ly/k90u50XTcgK

A week at JPM narrows the conversation fast. When meetings stack up, there’s less patience for vision and more interest in what actually works: what fits, integrates, gets paid for & where growth adds risk instead of reducing it. #JPM2026 #TeamHB #lifesciences

When a decision keeps coming back, it’s rarely about execution. It’s about whether the assumptions behind it and still true.